Strategic Focus Position Lykos as a public benefit biotech with a mental health focus, offering partnership potential around investigational psychedelics and regulatory-compliant clinical development support for PTSD and other conditions.

Financial Leverage Leverage their substantial funding and modest revenue to align with risk-sharing or milestone-based partnerships, offering scalable collaboration models that suit a and early-stage to mid-stage biotech with FDA interactions.

Leadership Transitions Monitor leadership changes and interim CEO appointments as potential signals for new strategic pivots; opportunities exist to engage CDM, medical affairs, and alliances teams during transition periods.

Operations & Compliance Prospect for technology and services that streamline regulatory submissions, trial management, data privacy, and vendor governance, given OneTrust, Sage Intacct, and Salesforce usage in their tech stack.

Collaboration Channels Target business development with structured proposals for strategic collaborations, research partnerships, and sponsored programs that align with their mission and public benefit status, especially in PTSD and CNS research.